Using a more sensitive ELISA kit in the current experiment, we confirmed significant increases in CCL17 and CCL22 BAL fluid levels in IPF patients as compared with those in CVD-IP patients and healthy volunteers. This evidence concerns the gene CCL17 and incontinentia pigmenti.